RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Amgen
A

Amgen portfolio

Amgen has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $270M.
Latest deal: Generate Biomedicines · Sep 14, 2023.
About this page

Its most recent investment on record is Generate Biomedicines's $270M Series B+ round in September 2023, alongside T. Rowe Price, Pictet Alternative Advisors, NVentures and 6 others. By category, its portfolio leans toward Health and bio (2) and Education (1).

What Amgen invests in

How Amgen invests

StageDealsCapital in rounds
Series B+ 1 100%$270M

Amgen portfolio companies

CompanyRound with AmgenTotal raisedLatest raise
GGenerate Biomedicines
Health and bio
Series B+ · $270M$640MSep 14, 2023
Series B+
AArboretum
Health and bio
backer$30MOct 6, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Amgen. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Amgen, which is a subset of its real portfolio. API: /api/v1/investors/amgen (get a free API key). More: the most active VC firms and new venture capital funds.